ストックスクリーナーアプリを入手
32.69
0.26%
-0.105
前日終値:
$32.79
開ける：
$32.85
24時間の取引高:
35,844
Relative Volume:
0.05
時価総額：
$1.87B
収益：
$656.11M
当期純損益:
$114.99M
株価収益率:
13.29
EPS:
2.46
ネットキャッシュフロー:
$212.78M
1週間 パフォーマンス:
-0.89%
1か月 パフォーマンス:
-6.42%
6か月 パフォーマンス:
+10.30%
1年 パフォーマンス:
+19.06%
1日の値動き範囲:
$32.33
$33.01
1週間の範囲:
$32.33
$33.66
52週間の値動き範囲:
$27.97
$41.61
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
名前
Harmony Biosciences Holdings Inc
セクター
電話
(484) 539-9800
住所
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
HRMY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| HRMY | 32.62 | 1.87B | 656.11M | 114.99M | 212.78M | 2.46 |
| VRTX | 448.31 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 743.42 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 588.87 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.79 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 103.31 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-21 | 開始されました | Citigroup | Buy |
| 2024-01-02 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-09-25 | ダウングレード | Goldman | Neutral → Sell |
| 2023-09-07 | 開始されました | Berenberg | Buy |
| 2023-04-20 | 開始されました | BofA Securities | Neutral |
| 2022-10-14 | アップグレード | Janney | Neutral → Buy |
| 2022-10-14 | アップグレード | Jefferies | Hold → Buy |
| 2022-08-03 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-13 | ダウングレード | Goldman | Buy → Neutral |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-04-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-04 | 開始されました | Raymond James | Outperform |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-03-29 | アップグレード | Goldman | Neutral → Buy |
| 2020-09-14 | 開始されました | Goldman | Neutral |
| 2020-09-14 | 開始されました | Jefferies | Buy |
| 2020-09-14 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Harmony Biosciences Holdings Inc (HRMY) 最新ニュース
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES - BioSpace
Harmony Biosciences to Present at Citi and Piper Sandler Healthcare Conferences | HRMY Stock News - StockTitan
Harmony Biosciences Reports Record Revenue and Plans Expansion in CNS Treatments - MSN
HRMY (Harmony Biosciences Holdings) GF Value Rank : 4 (As of Nov. 20, 2024) - GuruFocus.com
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Sold by Principal Financial Group Inc. - MarketBeat
Quest Partners LLC Acquires 20,689 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
First Week of July 2025 Options Trading For Harmony Biosciences Holdings (HRMY) - Nasdaq
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Sees Significant Drop in Short Interest - MarketBeat
14,396 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Purchased by CWA Asset Management Group LLC - MarketBeat
Harmony Biosciences’ Common Stock Offering - Global Legal Chronicle
Harmony Biosciences: sNDA Of WAKIX Brings Additional Value Inflection Points (NASDAQ:HRMY) - Seeking Alpha
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Harmony Biosciences director Antonio Gracias sells $139m in stock - Investing.com India
Marshman Fund Trust II sells $139.39 million in Harmony Biosciences stock - Investing.com
Harmony Biosciences director Antonio Gracias sells $139m in stock By Investing.com - Investing.com UK
AlphaCentric Advisors LLC Has $3.88 Million Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
There May Be Some Bright Spots In Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings - Yahoo Canada Finance
Top 5 US Stocks To Buy In November 2024 - Investing.com
HRMY vs. REGN: Which Stock Is the Better Value Option? - MSN
(HRMY) Trading Signals - Stock Traders Daily
Harmony Biosciences Holdings Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Earnings Beat: Harmony Biosciences Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now? - Yahoo Finance
Harmony Bio, The No. 1 Biotech Stock, Surges On Its 'High Quality' Beat - MSN
Harmony Biosciences Holdings Prices of Public Offering of Common Stock - citybiz
Harmony Biosciences chief commercial officer sells $870,018 in stock - Investing.com India
Harmony Biosciences chief commercial officer sells $870,018 in stock By Investing.com - Investing.com Canada
Latham Advises Harmony Biosciences Holdings, Inc. in Public Offering of Common Stock by Selling Shareholders - Latham & Watkins LLP
HRMY Makes Notable Cross Below Critical Moving Average - Nasdaq
Harmony Biosciences (NASDAQ:HRMY) Sees Strong Trading Volume Following Analyst Upgrade - MarketBeat
Cantor Fitzgerald Issues Positive Estimate for HRMY Earnings - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2024 Earnings Call Transcript - Insider Monkey
Harmony Biosciences Holdings, Inc. Just Recorded A 19% EPS Beat: Here's What Analysts Are Forecasting Next - Simply Wall St
Goldman Sachs maintains sell rating on HRMY stock with $28 target - Investing.com Canada
Harmony Biosciences Holdings Inc (HRMY) Q3 2024 Earnings Call Hi - GuruFocus.com
Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders - StockTitan
Harmony’s Wakix Surpasses $2B in Revenue, Data Shows Promise for IH Treatment - Sleep Review
Goldman Sachs maintains sell rating on HRMY stock with $28 target By Investing.com - Investing.com South Africa
Cantor Fitzgerald Raises Harmony Biosciences (NASDAQ:HRMY) Price Target to $58.00 - MarketBeat
Harmony Biosciences' (HRMY) "Outperform" Rating Reaffirmed at Oppenheimer - MarketBeat
Harmony Biosciences: Strong Q3 and Future Growth - MSN
Harmony Biosciences (NASDAQ:HRMY) Releases Earnings Results, Beats Expectations By $0.15 EPS - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Shares Gap DownHere's Why - MarketBeat
Is Harmony Biosciences Holdings (NASDAQ:HRMY) Using Too Much Debt? - Simply Wall St
Harmony Biosciences stock hits 52-week high at $40.73 By Investing.com - Investing.com Australia
Axonis Therapeutics Announces $115 Million Series A Financing - Quantisnow
Goldman Sachs Reiterates Sell Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider.com
Harmony Biosciences Holdings Inc (HRMY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ... - Investing.com Canada
HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUA - GuruFocus.com
Harmony Biosciences initiates public stock offering by shareholders By Investing.com - Investing.com South Africa
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Sees Large Decrease in Short Interest - MarketBeat
Harmony Biosciences Holdings Inc (HRMY) 財務データ
収益
当期純利益
現金流量
EPS
0.42%
0.16%
大文字化:
|
ボリューム (24 時間):